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1. Introduction 
a) Reason for Community action 
The approval by the Council on 28 June 1990 of Directive 90/394/EEC on the protection 
of workers from the risks related to exposure to carcinogens at work(1) was a major step 
forward in the improvement of protection of the health and safety of workers. 
This Directive, which was due to enter into force not later than 31 December 1992 at 
the latest, stipulates that employers must ensure that the level of exposure of workers 
is reduced to as low a level as is technically possible. 
It is also significant that the Directive provides for the establishment of limit values and 
on the basis of the available information, including scientific and technical data, in 
respect of all those carcinogens for which this is possible, and, where necessary, other 
directly related provisions. 
The main purpose of this proposal for an amendment to Directive 90/394/EEC is the 
resolve oft-reiterated by the various Community institutions to set limit values for 
occupational exposure to carcinogens, starting with benzene. The latter substance was 
in fact the subject of a proposal for a directive submitted by the Commission to the 
Council in January 1986 but which was not in the end adopted because of divergences 
between the Member States as regards certain limit values proposed, and particularly 
because of the stated aim to adopt a single directive covering carcinogens at the place 
of work. 
') OJ No L 196, of 26.7.1990, p. 1 
The wording of the existing directive also excludes, as regards the protection of workers, 
a whole series of preparations such as medicinal preparations, cosmetics and pesticides. 
The present modification removes this exclusion. 
Lastly, the submission of this amendment has also been taken as an opportunity to 
improve the wording of two specific points of Directive 90/394/EEC, viz. Art. 3(3) and 
Annex I (2), which had given rise to diverging interpretations in the different language 
versions. 
b) Subsidiarity 
The proposal does not breach the principle of subsidiarity, because it is only by 
Community action that a minimum level of protection for workers from the risks related 
to exposure to carcinogens can be assured in all Member States. This action will also 
avoid any distortion in the area of competitiveness by preventing the unequal application 
of minimum standards for worker protection in one or other Member States. 
Moreover this proposal will encourage more flexibility in cross border employment 
because workers can be reassured that they will find at least the minimum level of 
protection of their health and safety in all Member States. Employers will also be 
reassured that the costs of production will not be unduly distorted as a result of 
differences in the levels of protection of health and safety at work. 
2. Benzene 
Benzene is a colourless liquid and a normal constituent in petroleum; it is present in low 
concentrations in the natural environment. 
The extraction of benzene for commercial purposes dates from 1849, the benzene being 
derived from coal; today, however, approximately 90% of benzene is obtained by the 
distillation of petroleum, using various processes, such as fractional distillation of 
catalytic cracking. 
Benzene is mainly used as a raw material in the manufacture of organic compounds such 
as phenol, styrene, cyclohexone and maleic anhydride; as a component of petroleum, it 
is also present in petrol (4% on average in Europe). In the past benzene was widely 
used as a solvent, but this use is now being abandoned in the more highly industrialised 
countries, because of the risk to the health of the users. However, it is still used as a 
laboratory reagent, in the collection, preparation and extraction of samples. 
An estimated 7 million tonnes of benzene are produced in the Member States each year, 
mainly in the United Kingdom, the Federal Republic of Germany and the Netherlands. 
For at least 100 years benzene has been recognised as constituting a health risk for 
persons coming into contact with it. It enters the body almost exclusively via the 
airways; very small quantities can also be absorbed via the skin. 
Benzene's high fat solubility facilitates its distribution in tissues which are rich in lipids, 
such as the adipose tissue, the nervous system and the bone marrow. 
Benzene is rapidly oxidised in these tissues, mainly into phenol and also into catechol 
and hydroquinone. Whereas 25 to 50% of the benzene is eliminated in unchanged form 
by respiration, the remaining fraction is secreted, together with the oxidation products, 
in urine. 
Acute health effects are observed following exposure to high levels (over 500 ppm), 
with symptoms of poisoning. 
Prolonged exposure to toxic doses can, however, lead to changes in the bone marrow 
which may culminate in a persistent pancytopaenia, i.e. a reduction of all blood cell 
components. There may be early symptoms, such as anaemia, leukocytopaenia and 
thrombocytopaenia. In serious cases, the victim may develop aplastic anaemia provoked 
by a functional deficiency of the bone marrow. 
Numerous studies have shown that exposure to benzene at levels capable of provoking 
haemotoxic effects is associated with the appearance of chromosomal changes in the 
circulating lymphocytes and in the medullary cells; these changes may be reversible or 
irreversible, but their prognostic value has not yet been clarified. 
A certain number of cases of myeloblasts and erythroblastic leukaemia associated with 
exposure to benzene have been reported in the literature, and less frequently, cases of 
chronic myeloid or lymphoid leukaemia. Numerous epidemiological studies have 
revealed a significant correlation between exposure and the appearance of leukaemia. 
No conclusive survey has yet been conducted on the toxic and teratogenic effects of 
exposure to benzene during pregnancy. 
Benzene is a recognised dangerous substance and, as such, has long been covered by 
legal provisions in the Member States as regards occupational exposure; in particular, 
these provisions provide for: 
restrictions on use 
licensing arrangements for production 
use of preventive means 
an order that specific categories of workers may not be exposed. 
The Member States of the EU also use limit values for occupational exposure calculated 
in relation to a reference period of eight hours' work, primarily for use in monitoring the 
working environment and forestalling risks associated with exposure to benzene. These 
values range from 5-10 ppm (16 and 32 mg/m approximately) and are the result, in a 
certain number of countries, of specific calculations made by special committees, 
whereas in other countries the value published by the American Conference of 
Governmental Industrial Hygienists (ACGIH) has been adopted. 
It should be remembered that certain countries are in the process of examining the 
possibility of lowering the values. The trend is towards 1 ppm in two countries and 0.1 
ppm in another, the latter value being in line with the ACGIH proposal currently being 
examined in the USA. 
Considering the current situation in the different countries, the trends and the opinion 
expressed by a committee of high-ranking scientific experts, the limit value quoted in 
the current proposal for amending Directive 90/394/EEC could be a compromise 
between the requirements in terms of worker protection on the one hand, and technical 
constraints on the other. 
The temporary derogations to the limit value proposed in order to allow for the technical 
adjustments needed in certain workstations or for certain processes should not represent 
a specific risk for workers as long as the provisions of Directive 90/394/EEC are fully 
implemented. 
Therefore Annex III of Directive 90/394/EEC has to be amended. 
3. Scope of Directive 90/394/EEC 
The present wording of Article 2 (a) and (b) of Directive 90/394/EEC stipulates the 
carcinogens covered by its provisions as regards exposure. More particularly, they are 
described as the substances and preparations requiring labelling with the risk-phrase R45 
"may cause cancer" and in accordance with the terms of directives 67/548/EEC and 
88/379/EEC. 
In actual fact this definition substantially restricts the scope of the directive both as 
regards the substances whose inclusion is requested in Annex 1 of Directive 67/548/EEC 
and as regards preparations, many of which are not covered by Directive 88/379/EEC. 
In the latter instance, this is the case of medicinal and veterinary products, cosmetic 
products, mixtures of substances in the form of waste, pesticides, munitions and 
explosives, and food products. 
The need for an employee exposed to carcinogens to be protected in all working 
situations without exception has prompted the new wording in Article 2(a) i) and ii). 
It makes it possible to use for the classification of the carcinogen the criteria of 
Directive 67/548/EEC, irrespective of the fact that they are included in Annex I of the 
same directive, and at the same time to cover the substances classified with the label R 
49 "may cause cancer by inhalation"; it also makes it possible to avoid the differences 
which could result from the present restriction to preparations classified R45 under 
Directive 88/379/EEC in the levels of protection for workers exposed to preparations 
containing carcinogens. 
4. Amendment to Article 3(3) 
The new wording of the paragraph in the proposal is designed to establish an effective 
strategy for monitoring total exposure to carcinogens at the place of work. It is essential 
- particularly but not only - when exposure limit values are set, to take due account of 
the possibility of penetration through the skin as well as the respiratory absorption 
pathway. 
In certain cases, e.g. pesticides, the percentage of total body burden which can be 
attributed to absorption through the skin often significantly exceeds absorption via the 
respiratory pathway. 
Although the present wording was designed to secure the same objective, it specified 
only "harmful effects on the skin" as if to separate these from other effects on other 
parts of the body, without therefore considering the effects on health from an overall 
standpoint. 
5. Amendment to Annex I (2) 
When Directive 90/394/EEC was adopted by the Council it was quickly pointed out in 
various quarters that there was a discrepancy between the English text - the reference 
text - and the other language versions. 
While the stated aim was to protect workers against polycyclic aromatic hydrocarbons 
(PAH) present in certain by-products of coal, the language versions other than English 
drifted away from this objective, even including coal dust as such. 
The new wording proposed restores to the text the meaning it originally should have 
had. 
6. Consultations 
In accordance with the terms of Article 118A of the Treaty establishing the European 
Union, the European Parliament and Economic and Social Committee must be consulted. 
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Proposal for a Council Directive 
amending for the first time Directive 90/394/EEC 
on the protection of workers from the 
risks related to exposure to carcinogens at work 
THE COUNCIL OF THE EUROPEAN UNION, 
Having regard to the Treaty establishing the European Union, and in particular Article 
118a thereof, 
Having regard to Council Directive 90/394/EEC of 28 June 1990 on the protection of 
workers from the risks related to exposure to carcinogens at work(1) , and in particular 
Article 16, 
Having regard to the proposal from the Commission(2), drawn up following consultation 
with the Advisory Committee on Safety, Hygiene and Health Protection at Work, 
In cooperation with the European Parliament(3), 
Having regard to the opinion of the Economic and Social Committee(4), 
Whereas Article 118a of the Treaty provides that the Council shall adopt, by means of 
directives, minimum requirements for encouraging improvements, especially in the 
working environment, to ensure a better level of protection of the safety and health of 
workers; 
Whereas, under the terms of that Article, such directives are to avoid imposing 
administrative, financial and legal constraints in a way which would hold back the 
creation and development of small and medium-size undertakings, 
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Whereas Commission Directive 91/325/EEC(5) of 1 March 1991 adapting to technical 
progress for the twelfth time Council Directive 67/548/EEC(6) on the approximation of 
the laws, regulations and administrative provisions relating to the classification, 
packaging and labelling of dangerous substances introduces in Annex III new risk 
phrases to indicate the health hazards resulting from prolonged exposure and the risk of 
cancer through inhalation; 
Whereas in all work situations workers must be protected in respect of preparations 
containing one or more carcinogens; 
Whereas, for some agents it is necessary to consider all absorption pathways, including 
the possibility of penetration through the skin, in order to ensure the best possible level 
of protection; 
Whereas the wording of point 2 of Annex I to Directive 90/394/EEC relating to 
polycyclic aromatic hydrocarbons has posed problems of interpretation in many Member 
States; whereas, therefore, a new, more precise wording is called for; 
Whereas Article 16 of the aforementioned Council Directive 90/394/EEC makes 
provision for the establishment of exposure limit values on the basis of the available 
information, including scientific and technical data, in respect of all those carcinogens 
for which this is possible; 
Whereas occupational exposure limit values must be regarded as an important 
component of the general arrangements for the protection of workers; whereas such limit 
values must be revised whenever this becomes necessary in the light of more recent 
scientific data; 
Whereas benzene is a carcinogen which is present in many work situations whereas, 
therefore, a large number of workers are exposed to a potential health risk; whereas, 
although current scientific knowledge is not such that a level can be established below 
which risks to health cease to exist, a reduction in exposure to benzene will nonetheless 
reduce these risks; 
Whereas the respect of the minimum requirements on the protection of health and safety 
of workers from the specific risks related to carcinogens ensures not only the protection 
of the health and safety of each individual worker but also provides a level of minimum 
protection of all workers in the Community which avoids any possible distortion in the 
area of competitiveness; 
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Whereas provision should be made to ensure the protection of the health and safety of 
workers concerned, in the case of derogations provided for specified activities or sector 
of activity where the implementation of the limit value proposed for benzene may be 
difficult to meet within the date proposed; 
Whereas in most small and medium sized enterprises where the main use of benzene 
might be as a solvent, provisions to lower exposure will not be required as legal 
provisions already exist in nearly all the member States to restrict or prohibit its use. 
Whereas a consistent level of protection from the risks related to carcinogens has to be 
established for the Community as a whole and whereas that level of protection has to 
be set not by detailed prescriptive requirements but by a framework of general principles 
to enable Member States to apply the minimum requirements consistently; 
Whereas this amendment constitutes a practical aspect of the realisation of the social 
dimension of the internal market; 
Whereas, pursuant to Decision 74/325/EEC7, as last amended by the 1985 Act of 
Accession, the Advisory Committee on Safety, Hygiene and Health Protection at Work 
is to be consulted by the Commission with a view to drawing up proposals in this field, 
HAS ADOPTED THIS DIRECTIVE: 
Article 1 
Directive 90/394/EEC is hereby amended as follows: 
1. Article 2 shall be replaced by the following. 
"For the purposes of this Directive, 
(a) "carcinogen" means: 
i) a substance which meets the requirements for classification as category 
1 or 2 carcinogen according to the criteria of Annex VI of Directive 
67/548/EEC. 
OJNoL185, 9.7.1974, p. 15 
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ii) a preparation composed of one or more substances referred to in point 
(a)i) where the concentration of one or more of the individual substances 
meets the requirements for concentration limits for the classification of 
a preparation as a category 1 or 2 carcinogens set out either: 
- in Annex I to Directive 67/548/EEC 
or 
- in Annex I of Directive 88/379/EEC where the substance or 
substances do not appear in Annex I to Directive 67/548/EEC or 
appear in it without concentration limits. 
iii) a substance, preparation or process referred to in Annex I as well as a 
substance or preparation released by a process referred to in Annex I. 
(b) "limit value" means, unless otherwise specified, the limit of concentration 
for a "carcinogen" in the air within the breathing zone of a worker." 
2. Article 3(3) shall be replaced by the following: 
"Furthermore, when assessing the risk, account shall be taken of all other routes of 
exposure, such absorption into and/or through the skin". 
3. In Article 16, the following paragraph shall be added: 
"3. In the case of derogations provided for in Annex III, the Member States shall 
be obliged to ensure that employers comply with procedures and measures in order 
to take adequate precautions to protect the health and safety of the workers 
concerned." 
4. Item 2 of Annex I shall be replaced by the following: 
"Work involving exposure to polycyclic aromatic hydrocarbons present in coal soot, 
coal tar or coal pitch". 
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5. Part A of Annex III shall be replaced by the following: 
"A. LIMIT VALUES FOR OCCUPATIONAL EXPOSURE 
Name of agent EINECS (1) CAS (2) Limit values 
mg/m3 (3) ppm (4) 
Notation Derogations 
Benzene 200-753-7 71-43-2 3.25 (5) 1(5) Skin (6) Limit value: 3 ppm 
(= 9.75 mg/m3) until 31 December 
2000 for the following activities or 
sector of activity: 
- Selected sites in coke plants 
(primary coolers, benzol/sulphate 
houses, benzol storage and 
loading) 
- cleaning and maintenance of tanks 
- loading and unloading of tanker 
vessels and lorries 
- marine transport 
- motor vehicle repair shops 
- service station with filling 
attendant 
(1) EINECS: European Inventory of Existing Chemical Substances 
(2) CAS: Chemical Abstract Service Number 
(3) mg/m3 = milligrams per cubic metre of air at 20*C and 101,3 KPa (760 mm 
mercury pressure) 
(4) ppm = parts per million by volume in air (ml/m3). 
(5) Measured or calculated in relation to a reference period of eight hours. 
(6) Substantial contribution to the total body burden via dermal exposure possible." 
Article 2 
Member States shall bring into force the laws, regulations and administrative 
provisions necessary to comply with this Directive not later than 31 December 
1998. They shall forthwith inform the Commission thereof. 
When Member States adopt these provisions, these shall contain a reference to 
this Directive or shall be accompanied by such reference at the time of their 
official publication. The procedure for such reference shall be laid down by the 
Member States. 
M 
Member States shall communicate to the Commission the texts of the provisions 
of national law which they adopt in the field covered by this Directive 
Article 3 
This Directive is addressed to the Member States. 
Done at Brussels, 
For the Council 
The President 
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IMPACT ASSESSMENT FORM 
The impact on business 
of the proposal for a Council Directive 
amending for the first time Directive 90/394/EEC 
on the protection of workers from the risks 
related to exposure to carcinogens at work. 
I. Rationale for the proposal 
Article 16 of Council Directive 90/394/EEC of 28 June 1990 stipulates that the 
Council shall set out limit values for exposure at the place of work on the basis of 
the available information, including scientific and technical data, in respect of all 
those carcinogens for which this is possible. The Commission was subsequently 
called upon by various parties during the different phases of consultation to submit 
a preliminary proposal covering benzene. 
It is mainly to cater for these requests that the Commission is now submitting this 
text to the Council. The other amendments proposed concerning partly the 
definition of carcinogen and partly changes in wording, can be considered incidental 
and without any specific impact other than that requested under the original 
directive. Only in the event that the definitions should be expanded need the other 
industrial sectors covered by the Directive be involved. 
The principle of subsidiarity is complying with as indicated in the introduction to 
the explanatory memorandum. 
H. The impact on business 
1) Characteristics of the firms concerned 
As a major raw material used in the chemical industry, benzene is a 
constituent of many items found in homes, offices, and factories. Worker 
exposures to benzene can occur during the production, use and transportation 
of benzene as well as during the production and use of chemicals, liquid 
mixtures and solvents that contain benzene as a natural ingredient, an 
intentional ingredient, or a contaminant. The main sources of potential 
benzene exposures and the industries in which they can occur are listed below: 
a) production of benzene (petrochemical producers, petroleum refineries, 
producers of coke in the iron and steel industry), 
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b) transportation and storage of benzene and benzene-containing liquids, 
c) production of products containing benzene as a natural ingredient, 
d) production of products using liquid mixtures containing solvents, e.g. 
rubber products, paints, glues, inks.... 
e) use of pure benzene as a process solvent, e.g. the perfume industry, in 
addition to those listed in d). 
2) Size of business 
Generally speaking, the arrangements cover more often than not medium and 
large-sized companies involved inter alia in production activities. In the small 
and medium-sized enterprises, where benzene might be used mainly for its 
qualities as a solvent, the legal provisions which exist in nearly all the 
Member States to restrict or prohibit its use, limit the scope of the directive. 
Only in respect of research laboratories and small companies producing 
perfumes would provisions designed to lower exposure levels be required. 
3) Geographical area 
No specific geographical distribution does exist for these businesses. 
4) Obligations on enterprises 
Establishing a limit value for occupational exposure to benzene implies the 
additional obligation on companies to adhere to this value, the value itself 
being the average weighted value of exposure for the worker during an 8-hour 
working cycle. 
This definition needs to be stressed given that in a great many industrial 
situations where the concentration of benzene in the ambient air exceeds the 
limit value for exposure, the worker is often exposed for short periods and this 
leads to a substantial lowering of the average weighted value. 
In order to allow for certain specific difficulties arising from the nature of the 
work station, the proposal provides for certain temporary derogations to the 
limit value by establishing a higher value which, considering the actual time 
and the number of workers involved, should only negligibly increase the risk 
to health. 
1*1 
5) Effects on the competitiveness of companies 
a) Advantages 
The advantages of improved working conditions, in this particular case 
meaning a lowering of the exposure level, will result in a lowering of the 
number of cases of leukaemia, as has also been stressed (and evaluated) 
by the committee of scientific experts. 
These benefits will be felt not only by individual workers as members of 
society but also by the companies themselves, for which the cost 
advantages will be expressed as: 
fewer absences through illness 
lower retraining costs, and, 
fewer cases of persons having to be pensioned off because of 
invalidity. 
b) Disadvantages 
Two types of additional expenditure will have to be incurred, the first 
concerning the actual measuring of the limit value for exposure and, the 
second, arising from modifications on the older items of plant and 
equipment to the systems for preventing the release of benzene vapours 
into the ambient air. 
The costs as regards the first provision may obviously be comparatively 
low as there is no absolute need for companies to have their own 
measuring instruments. The second aspect will undoubtedly weigh more 
heavily, particularly in the older installations, although the actual scale 
of intervention can be limited in this case, too, as was pointed out 
previously, to those work stations where the worker actually carries out 
his tasks. 
Nevertheless, as these arrangements are designed to protect the worker 
against the risks of the onset of leukaemia, the cost/benefit ratio should 
have a substantial impact. 
Lastly, there should be no significant effects on competitiveness or on 
employment levels. 
HI. Consultation 
The Advisory Committee on Safety, Hygiene and Health Protection at Work gave 
its opinion on this proposal and agreed on its need, namely as concerns the 
amendment to the field of application of the Directive. 
As regards benzene, the proposed value was not generally agreed among the 
different Parties, even if the groups unanimously agreed that 1 ppm should be 
regarded as feasible within a reasonable period. 
Thus a system of derogations, limited in time, has been incorporated into the 
proposal itself in order to allay the misgivings expressed by the representatives of 
the industrial sector as to the applicability of this exposure limit value. 
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